Article Data

  • Views 385
  • Dowloads 109

Original Research

Open Access

Ovarian cancer after kidney transplantation

  • C. Di Berardino1
  • G. Mascaretti1,*,

1Department of Ostetrics and Gynecology, University of L’Aquila, Italy

DOI: 10.12892/ejgo20080189 Vol.29,Issue 1,January 2008 pp.89-92

Published: 10 January 2008

*Corresponding Author(s): G. Mascaretti E-mail: giulio.mascaretti@libero.it

Abstract

Malignancies are one of the major causes of morbidity and mortality in transplant patients. The incidence is progressively increasing either because of the increased age transplant patients and the increase of immunosuppressive therapy or the increased follow-up range post-transplantation. The main causes of increased tumor incidence in transplant patients with respect to the general population are the reduced immunosurveillance and the high incidence of infections due to oncogenic viruses. This problem might become more and more serious in the near future due to the introduction of new inummosuppressive strategies that significantly extend allograft survival. A case of ovarian cancer in a kidney transplant patient is described. Attention is focused on the potential dual role of immunosuppressive therapy in the development of malignancies in transplant patients.

Keywords

Ovarian cancer; Kidney transplantation; Immunosuppressive drugs

Cite and Share

C. Di Berardino,G. Mascaretti. Ovarian cancer after kidney transplantation. European Journal of Gynaecological Oncology. 2008. 29(1);89-92.

References

[1] Bower M.: “The management of lymphoma in the immunosuppressed patient”. Best Pract. Res. Clin. Haematol., 2002, 15, 517.

[2] Winter P., Schoeneich G., Miersch W.D., Klehr H.U.: “Tumor induction as a consequence of immunosuppression after renal transplantation”. Int. Urol. Nephrol., 1997, 29, 701.

[3] Baccarani U., Adani G.L., Montanaro D., Risaliti A., Lorenzin D., Avellini C. et al.: “De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases”. Tranplant. Proc., 2006, 38, 1135.

[4] Penn I.: “Depressed immunity and development of cancer”. Cancer Detect. Prev., 1994, 18, 241.

[5] Penn I.: “Second malignant neoplasm associated with immunosoppressive medication”. Cancer, 1976, 37, 1024.

[6] Penn I.: “Malignancies associated with renal transplantation”. Urology, 1997, 10, 57.

[7] Ramsay H.M., Fryer A.A., Reece S., Smith A.G., Harden P.N.: “Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients”. Am. J. Kidney Dis., 2000, 36, 167.

[8] Penn I.: “Post transplan malignancies”. Transplant Pro., 1999, 31, 1260.

[9] United Network For Organ Sharing, www.unos.org, 2003.

[10] Penn I.: “Immunosuppression – a contributory factor in lymphoma formation”. Clin. Transplant, 1992, 6, 214.

[11] Stallone G., Infante B., Schena A., Grandaliano G., Di Paolo S., Scolari M.P. et al.: “Malignant neoplasia and renal transplant”. Italian J. Nefrol., 2003, 20, 611.

[12] Kasiske B.L., Snyder J.J., Gilbertson D.T., Wang C.: “Cancer after kidney transplantation in the United States”. Am. J. Transplant, 2004, 4, 905.

[13] Boshoff C.: “Kaposi’s sarcoma biology”. IUBMB Life, 2002, 53, 259.

[14] Meier-Kriesche H., Ojo A., Hanson J., Kaplan B.: “Exponentially increased risk of infectious death in older renal transplant recipients”. Kidney Int., 2001, 59, 1539.

[15] Penn I.: “Malignancy after immunosuppressive therapy : how can the risk be reduce?”. Clin. Immunotherapy, 1995, 4, 207.

[16] Infante B., Stallone G., Schena A. et al.: “Pro and anti-neoplastic effects of immunosuppressive drug in renal transplantation”. Ital. J. Nefrol., 2006, 23, 389.

[17] Kahan B.D.: “Cyclosporine”. N. Engl. J. Med., 1989, 321, 1725.

[18] Masuhara M., Ogasawara H., Katyal S.L., Nakamura T., Shinozuka H.: “Cyclosporine stimulates hepatocyte proliferation and accelerates development of hepatocellular carcinomas in rats”. Carcinogenesis, 1993, 14, 1579.

[19] Hojo M., Morimoto T., Maluccio M., Asano T., Morimoto K., Milagros Lagman M. et al.: “Cyclosporine induces cancer progression by a cell-autonomous mechanism”. Nature, 1999, 397, 530.

[20] Herman M., Weinstein T., Korzets A., Chagnac A., Ori Y., Zevin D. et al.: “Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients”. J. Lab. Clin. Med., 2001, 137, 14.

[21] Twentyman P.R., Fox N.E., White D.J.: “Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistent human lung cancer cell line”. Br. J. Cancer, 1987, 56, 55.

[22] Veroux M., Pulitati C., Fiamingo P.: “Early de novo malignances after kidney transplantation”. Transplant Proc., 2004, 36, 718

[23] Startzl T.E., Nalesnik M.A., Porter K.A.: “Reversibility of lynphomas and lynphoproliferatuive lesion developig under cyclosporin-steroid therapy”. Lancet, 1984, 1, 583.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top